Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01909076 · ClinicalTrials.gov registry record · NA

Transforming Opioid Prescribing in Primary Care

A NA study of Chronic Pain and Opioid-Related Disorders, sponsored by Boston Medical Center.

Completed
Registry status
NA
Development phase
53
Enrollment target
1
Study location

NCT01909076: Completed NA study of Chronic Pain and Opioid-Related Disorders, sponsored by Boston Medical Center.

NCT01909076 is a NA study of Chronic Pain and Opioid-Related Disorders that has completed, run by Boston Medical Center. The registered enrollment target is 53 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01909076, a NA study of Chronic Pain and Opioid-Related Disorders, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target
1
Study location

Study Summary

Prescription opioid misuse is a significant public health problem as well as a patient safety concern. Primary care providers are the leading prescribers of opioids for chronic pain, yet few providers follow standard practice guidelines regarding assessment and monitoring. The investigators propose a novel system change in delivery of primary care services to decrease misuse of and addiction to prescription opioids for patients with chronic pain. The proposed intervention for the overall project includes a nurse-managed registry for planning individual patient care and conducting population-based care for a population of patients receiving opioids for chronic pain. Academic detailing to clinicians is another effective way to improve care. Finally, the researchers will create a knowledge management tool to facilitate guideline adherence. This tool will be accessible via an internet link, and will include validated instruments to assess patient status and also to facilitate physician adherence to suggested monitoring.

Primary Outcome

The primary outcomes is PCP adherence to chronic opioid therapy guidelines and is defined as whether a PCP's patient has 1. a signed opioid treatment agreement (ever) and 2. urine drug testing (at least 1 completed urine drug test for controlled substances at any point during opioid treatment).

Interventions

  • BEHAVIORAL Electronic decision support tools
  • BEHAVIORAL Enhanced patient education materials
  • BEHAVIORAL Nurse care management
  • BEHAVIORAL Electronic Patient Registry
  • BEHAVIORAL Academic detailing

Study Locations (1)

Massachusetts

  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2014-01
Est. Completion 2016-03
Phase NA
Boston Medical Center

253 total trials

What the finished NCT01909076 record still lists

NCT01909076 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (93% lower).

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 5 interventions - of which Electronic decision support tools is the first listed.

NCT01909076 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01909076 about?

NCT01909076 is a clinical study titled "Transforming Opioid Prescribing in Primary Care". Prescription opioid misuse is a significant public health problem as well as a patient safety concern. Primary care providers are the leading prescribers of opioids for chronic pain, yet few providers follow standard practice guidelines regarding assessment and monitoring. The investigators propose ...

What is the current status of trial NCT01909076?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2014-01. Estimated completion is 2016-03.

What conditions does trial NCT01909076 study?

This clinical trial studies the following conditions: Chronic Pain, Opioid-Related Disorders.

What interventions are being tested in trial NCT01909076?

The interventions under investigation include: Electronic decision support tools (BEHAVIORAL), Enhanced patient education materials (BEHAVIORAL), Nurse care management (BEHAVIORAL), Electronic Patient Registry (BEHAVIORAL), Academic detailing (BEHAVIORAL).

Who is sponsoring clinical trial NCT01909076?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01909076 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01909076's enrollment target sits among peer trials

53 194th of 301 higher than 108 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04177004 · 53 participants · Phase 1

    Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

  • NCT04199741 · 53 participants · Phase 1

    PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

  • NCT04835129 · 53 participants · Phase 2

    Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

  • NCT04913805 · 53 participants · Phase 2

    Matching Perfusion and Metabolic Activity in HFpEF

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01909076, the US trial registry maintained by the National Library of Medicine. NCT01909076 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.